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Abstract
Background
Lung cancer symptoms are vague and difficult to detect. Interventions are needed to pro-
mote early diagnosis, however health services are already pressurised. This study explored
symptomology and help-seeking behaviours of primary care patients at ‘high-risk’ of lung
cancer (50 years old, recent smoking history), to inform targeted interventions.
Methods
Mixed method study with patients at eight general practitioner (GP) practices across south
England. Study incorporated: postal symptom questionnaire; clinical records review of par-
ticipant consultation behaviour 12 months pre- and post-questionnaire; qualitative partici-
pant interviews (n = 38) with a purposive sample.
Results
A small, clinically relevant group (n = 61/908, 6.7%) of primary care patients was identified
who, despite reporting potential symptoms of lung cancer in questionnaires, had not con-
sulted a GP12 months. Of nine symptoms associated with lung cancer, 53.4% (629/
1172) of total respondents reported1, and 35% (411/1172) reported2. Most partici-
pants (77.3%, n = 686/908) had comorbid conditions; 47.8%, (n = 414/908) associated with
chest and respiratory symptoms. Participant consulting behaviour significantly increased in
the 3-month period following questionnaire completion compared with the previous 3-
month period (p = .002), indicating questionnaires impacted upon consulting behaviour.
Symptomatic non-consulters were predominantly younger, employed, with higher multiple
deprivation scores than their GP practice mean. Of symptomatic non-consulters, 30% (18/
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61) consulted1 month post-questionnaire, with comorbidities subsequently diagnosed for
five participants. Interviews (n = 39) indicated three overarching differences between the
views of consulting and non-consulting participants: concern over wasting their own as well
as GP time; high tolerance threshold for symptoms; a greater tendency to self-manage
symptoms.
Conclusions
This first study to examine symptoms and consulting behaviour amongst a primary care
population at ‘high- risk’ of lung cancer, found symptomatic patients who rarely consult
GPs, might respond to a targeted symptom elicitation intervention. Such GP-based inter-
ventions may promote early diagnosis of lung cancer or other comorbidities, without bur-
dening already pressurised services.
Introduction
Lung cancer is the secondmost common cancer worldwide with 43,500 new diagnoses per
year in the UK, 410,00 in Europe and 1.83m worldwide[1], and has the lowest survival rate of
all cancer sites [2]. The mean doubling time for lung cancer is 125 days, but may be as rapid as
7.5 days, with two-thirds diagnosed at late stage when curative options are limited[2]. One-
and five-year survival rates are lower in the UK than other European countries[3,4], which
may be partly related to the structure of primary care[5]. Even small improvements in timing
of lung cancer diagnosis could significantly improve survival[6]. Consequently, early diagnosis
of lung cancer is a priority for the National Awareness and Early Diagnosis Initiative (NAEDI)
in England[7], with a national symptom awareness campaign conducted in 2012[8].
Diagnosis of lung cancer may be partly delayed by late patient presentation in primary care.
This may result from extended patient appraisal intervals (time taken to recognise and inter-
pret bodily changes) and help-seeking intervals (time taken to act on symptoms)[9,10]. In
terms of the appraisal interval, evidence indicates patients often either fail to recognise early
symptoms as potentially indicative of cancer[11,12], or else normalise them by attributing
them to aging processes, lack of fitness or comorbidities[13,14]. Reasons for longer help-seek-
ing intervals include: fear of consultation; gender differences (e.g. men less ready to seek help
than women); and need for ‘sanctioning’ by others[13]. Long-term smokers, those with COPD
and/or those living alone are at particular risk of taking longer to consult with symptoms of
lung cancer[15]. Once patients consult General Practitioners (GPs), they may not report all
their symptoms or describe them in relation to everyday experiences rather than as possible
signs of ill health[16]. Timely diagnosis also relies upon the skill of clinicians to elicit symptom
history in consultations; their knowledge levels and attitudes, and; access to and organisation
of health care[17,18]. Lung cancer has been classified as ‘harder to suspect’ than most cancers
[19], while GPs encounter few patients presenting with new lung cancers each year, giving rela-
tively little experience in diagnosis[2].
The aim of this study was to explore the help-seeking behaviour of patients at ‘high-risk’ of
lung cancer, who had symptoms indicative of lung cancer, and to better understand barriers
and faciliators to help-seeking amongst symptomatic patients who rarely consut GPs. Better
understanding of help seeking behaviours amongst this group will facilitate the development of
appropriate interventions to target individuals most at risk of lung cancer without burdening
already pressurised services.
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Methods
Sample and Data Collection
Eight GP practices from three counties in south England participated in the study, and identi-
fied individuals at ‘high-risk’ of developing lung cancer (>50 years old with smoking history
within previous 10 years) from practice lists. Practices mailed potential participants a 10-page
version of the IPCARD (Identifying Symptom Predictors of Chest and RespiratoryDisease)
questionnaire, previously developed by members of the research team[20,21]. IPCARD asks
individuals about the presence, severity, progression and chronicity of nine symptoms often
reported by patients recently diagnosedwith lung cancer[20,22]: tiredness; breathing changes;
chest and upper body aches; cough; coughing up blood; non-menopausal sweats; ongoing
voice changes; unintentional weight loss; and noticeably more chest infections over a 12 month
period.Questionnaires also included socio-demographicquestions. Data collection took place
between June 2012 and January 2013. Participants’ consulting behaviours 12 months pre and
post the date of questionnaire completion were extracted from electronic records at GP prac-
tices and recorded using standardised data extraction forms.
Respondents (n = 38) representing different categories of self-reported symptom profiles
(symptom combinations, chronicity and severity), socio-demographic characteristics, smoking
status and self-reportedGP consulting behaviour over the previous 12 months were purpo-
sively sampled for semi-structured interviews.One researcher (EJ) conducted interviews,
exploring help-seeking intentions and factors promoting or inhibiting help-seeking behaviour.
Ethics
Ethical approval for the study was secured from the National Research Ethics Service (NRES)
Committee South Central-SouthamptonA on 20/05/2012 (12/SC/0049). Completed question-
naires returned to the research team (n = 1172) implied consent for their responses to be included
in the study. Separate consent forms, sent with study invitation, were signed by participants to
consent for medical records review (n = 908). Further separate written consent was given prior to
interviews (n = 38). This procedure received approval from the above ethics committee.
Statistical Analysis
Data from questionnaires and clinical notes were initially entered into the same SPSS database,
and then exported to Stata 13.1 for analysis. Descriptive and inferential statistics were used to
explore variables and relationships between variables. Paired sample t-tests were used to com-
pare the mean number of consultations for symptoms indicative of lung cancer for the 12
months and three months pre- and post each participant’s completion of the questionnaire,
and 95% confidence intervals were calculated around the difference in proportion of those
attending GP consultations for the same periods[23].
Negative binomial regression was used to model GP visits in the year post-questionnaire
and to identify the variables most strongly associated with number of GP visits. GP visits prior
to the questionnaire, total number of symptoms, number of comorbidities, age group, gender
and site were a priori included in the model. Remaining variables (e.g. employment, education
and domestic status) were included or excluded in the model based on size of incidence rate
ratios (IRRs) and associated p-value. Statistical analysis was conducted by SE, LB and RW.
Qualitative Analysis
Interviewswere transcribed verbatim and analysed for themes using the computer programme
NVivo 10 to facilitate thematic content analysis[24]. Codingwas conducted by three
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experiencedqualitative researchers (EJ, LB, RW). Each researcher independently coded one
interview and discussed their findings with the full research group to agree upon emerging
themes. Thereafter, regular two weekly discussions were conducted between the three research-
ers to review the development of the thematic framework and ensure analytical rigour. CR also
contributed to later stages of analysis.
Results
Of 4622 individuals identified as being at high-risk of developing lung cancer and invited to
participate in the survey, 1172 (25.3%) completed and returned the questionnaire (response
rates varied across practices: 19%-29%). Of these, clinical note reviews were completed on 908
respondents (77.5%). Table 1 indicates the characteristics of respondents. There was evidence
of association between age group and participation (X2(3) = 20.4, p< .001), which appears, at
least in part, to be explained by a lower participation rate in the age 50–59 year old group. Par-
ticipation was also independently associated with levels of social deprivation, with those in the
most socially deprived quintile least likely to participate compared to other quintiles (X2(4) =
158.9, p< .001). There were also significant variations in participation between practices (X2(7)
= 21.6, p = .011).
During the study period, three participants were diagnosedwith lung cancer/mesothelioma,
within a range of 4 weeks–11months post-completion of questionnaire. Each of the diagnosed
individuals had one or more comorbidities (i.e. asthma, hypertension, cardiovascular disease)
and all reported three or more symptoms in their questionnaire, but which were not specifically
referred to in their notes. The patients were not being investigated for potential lung cancer at
questionnaire completion,and two died within eight and five months respectively from
diagnosis.
Symptom and Comorbidity Prevalence
A high prevalence of symptoms associated with lung cancer was reported. As Table 2 shows,
53.6% (629/1172) of all respondents reported experiencing at least one and 35% (n = 411) two
or more of 9 symptoms potentially indicative of lung cancer within the previous three months.
Table 2 also shows the percentage of participants who reported each of the symptoms and their
chronicity. Almost a third (31.8%) of respondents reported tiredness: for 25.4% (n = 287/1172)
this was experienced in combination with other symptoms. Other prevalent symptoms
included breathing changes (28.3%, n = 323), increased chest infections over the previous year
(24.9%, n = 292), chest aches/pain (17.3%, n = 192) and cough (13.9%, n = 161). Over a third
(37.4%, n = 439) of respondents reported having first experienced at least one symptom >12
months previously (Table 2).
Of respondents included in the clinical notes review, 77.3% (n = 686/908) were found to
have at least one comorbidity, 35% (n = 313/908) to have two or more. Many participants
(47.8%, n = 414/908) were living with comorbidities that might impact on their respiratory
function,most commonly Chronic ObstructiveAirways Disease (COPD) (n = 89/908, 9.8%),
asthma (n = 71/908, 7.8%) and cardiac disease (n = 79/908, 8.7%). Using Chi2, a positive associ-
ation was found between those participants reporting symptoms in the questionnaire and
those found to be living with comorbidities (X(1) = 15.8, p< .001). These findings indicate
symptoms associated with lung cancer are very common amongst this group of high-risk
patients and are likely often? caused by other common conditions.
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GP Consulting Behaviour
Note reviews found that 216 respondents collectively consulted their GP for potential lung can-
cer symptoms on a total of 355 occasions in the 12 months pre-questionnaire, compared with
247 respondents consulting on 415 occasions in the 12 months following the questionnaire: an
increase of 14.4%. Using McNemar’s difference in proportions, we found an increase of 3.4%
(95% CI: 0.0, 6.8) in overall consultations between the 12 months pre-questionnaire compared
with post-questionnaire, and a significant increase of 4.2% (95% CI: 1.8, 6.5) in the number of
consultations between the three months pre- and post-questionnaire (Table 3). Almost half the
participants (45.4%, 413/908) for whomwe have consultation data reported symptoms in ques-
tionaiires for which they did not consult the GP.
Paired sample t-tests compared the mean number of consultations for each of these symp-
toms for the 12 months and three months pre- and post completion of the questionnaire. Anal-
ysis found that only consultations for chest infections increased significantly over the 12
month period (p = .006): the overall increase of consultations for symptoms potentially indica-
tive of lung cancer just missed statistical significance (p = .051). However, a significant increase
was found in the mean number of GP consultations for symptoms in the three months follow-
ing the completion of the questionnaire, amongst this sample (M = 0.1244, SD = 0.40523),
compared with the three month period before participants received the questionnaire
(M = 0.0727, SD 0.32398); p = .002), with significant increases for both chest infections (p =
.002) and cough (p = .042). Moreover, the proportional increases for consulting behaviour in
the 3-month period following receipt of the questionnaire for some symptoms (i.e. chest infec-
tions: 94.4% (p = .002); cough: 56.5% (p = .042); chest pain: 28.5% (p = .532), and; breathing
Table 2. Symptom prevalence and chronicity reported in the questionnaire (n = 1172).
Symptoms indicative of lung cancer % of patients reporting each
Symptom in the questionnaire
% of patients reporting symptoms
in combination with other
symptoms
% patients reporting chronicity of
symptoms
 3
months
4–12
months
>12
months
1 Tiredness 31.8% (n = 351) 25.4% (n = 287) 13.3%
(n = 47)
29.3%
(n = 103)
57.3%
(n = 201)
2 Breathing changes 28.3% (n = 323) 23.2% (n = 265) 8.6%
(n = 28)
18.6%
(n = 60)
72.7%
(n = 235)
3 Chest and upper body aches,
pain or discomfort
17.3% (n = 192) 15.1% (n = 168) 9.8%
(n = 19)
16.6%
(n = 32)
73.4%
(n = 141)
4 Cough 13.9% (n = 161) 8.9% (n = 104) 19.8%
(n = 32)
22.3%
(n = 36)
57.8%
(n = 93)
5 Coughing up blood 0.1% (n = 1) 0.1% (n = 1) 0.0%
(n = 0)
100%
(n = 1)
0.0%
(n = 0)
6 Non-menopausal hot or cold
sweats
15.7% (n = 184) 13.0% (n = 149) 10.3%
(n = 19)
19.5%
(n = 36)
70.1%
(n = 129)
7 Noticeably more chest infections
within the previous 12 months
24.9% (n = 292) 14.5% (n = 170) - - -
8 Unintentional weight loss within
the previous 12 months
14.2% (n = 165) 8.9% (n = 104) - - -
9 Ongoing voice changes within
the previous 12 months
10.2% (n = 120) 9.0% (n = 103) - - -
Total number of patients reporting
symptoms
53.6%, (n = 629)1 35.1% (n = 411)1 9.3%
(109)1
17.4%
(205)1
37.4%
(439)1
Note
1 = Totals are not the sum of all respondents/consultations within the column as many respondents consulted for more than one symptom
doi:10.1371/journal.pone.0165677.t002
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changes: 60% (p = .057)) were greater than the proportional increases for these symptoms in
the overall 12 month period. This finding suggests that completing the IPCARD questionnaire
may have encouraged participants to increase their consulting behaviour, but that most of this
increase occurred in the short term.
Negative binomial regression identified those variables most strongly associated with post-
questionnaire GP visits. In order of inclusion, the variables completing the model were employ-
ment status, domestic status (married/single etc.), highest qualification attained and severity of
breathlessness. Squared terms for pre-questionnaire visits, symptoms and comorbidities were
also tested (Table 4). Higher numbers of reported symptoms (p< .001), increased total num-
ber of comorbidities (p< .001), and increased pre-questionnaire visits (p< .001) were all inde-
pendently associated with increased post-questionnaire GP visits. Of the symptoms, only the
reported severity of breathlessness was associated with GP visits, and was highly correlated
with the total number of symptoms reported by participants, meaning those with more
reported symptoms had more severe breathing changes. There was noticeable variation across
sites.
Table 4. Negative binomial Regression analysis: Participant characteristics and consultation
behaviour.
Variable* IRR 95% CI p-value
Pre-questionnaire GP visits
Linear term 1.084 1.064–1.104 < .0005
Squared term 0.999 0.998–0.999 < .0005
Total symptoms 1.094 1.043–1.147 < .0005
Number of comorbidities 1.151 1.089–1.216 < .0005
Gender (ref. male) 1.082 0.955–1.226 .215
Age group (ref. 50–59 years)
60–69 1.128 0.944–1.347 .185
70–79 1.315 1.047–1.653 .019
80+ 1.442 1.081–1.924 .013
Employment (ref. full-time)
Part-time 0.686 0.532–0.884 .004
Retired 0.833 0.687–1.011 .065
Other 0.842 0.650–1.090 .192
Domestic (ref. married)
Single 1.082 0.837–1.398 .547
Divorced/separated 0.959 0.805–1.144 .644
Widowed 1.298 1.060–1.589 .012
Living with partner 1.115 0.877–1.416 .374
Highest qualification (ref. none)
GCSE/O-level 0.933 0.786–1.109 .432
A-level 0.786 0.629–0.982 .034
Degree 0.924 0.762–1.119 .418
MA, PhD 1.076 0.788–1.469 .646
Vocational 0.949 0.796–1.130 .555
Severity breathlessness 0.965 0.937–0.993 .015
*Site not shown; IRRs ranged from 1.007 (95% CI [0.769, 1.320]) to 1.549 (95% CI [1.179, 2.035]).
Parameter α (to model additional dispersion in negative binomial model) estimated as 0.289 (95% CI [0.229,
0.365]).
doi:10.1371/journal.pone.0165677.t004
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Symptomatic Non-Consulters
Of all participants whose notes were reviewed, 126/908 (13.8%) were found not to have
attended their GP practice for any reason for 12 months prior to the survey (Table 2 shows
socio-demographic characteristics of these participants). For many this was unsurprising, as
they had reported no symptoms. However, 61/126 non-attenders (48.4%) had reported symp-
toms in the questionnaire, and of these 42/61 (68.8%) had no diagnosed comorbidities to
which experienced symptoms were potentially attributable (Table 1). Therefore, a group of
non-attenders with potential lung cancer symptoms were identified (61/908; 6.7% of respon-
dents), most of whom did not have a diagnosis of chest or respiratory disease that might
explain symptoms (42/908% of respondents).
Symptomatic non-consulters were predominantly male (35/61, younger (mean/median age:
61.8/59 years; range 50–93), employed (32/61) and had index of multiple deprivation (IMD) scores
lower than their GP practice average. Within onemonth of completion of the IPCARDquestion-
naire, 29% (18/61 29%) symptomatic participants who had not consulted their GP for 12 months
subsequently consulted their GPs for their symptoms. Following GP consultation, six were treated
for chest infections (all of whom attended for cough), nine were given health checks and/or lifestyle
counselling (including smoking cessation advice), and five had previously unknown comorbidities
diagnosed (e.g. COPD, emphysema, asthma, hypertension and depression) (Table 5). Eight symp-
tomatic non-consulters consulted for symptoms potentially indicative of lung cancer within 2–12
months of completing the questionnaire (see Fig 1). Of the 37 participants who did not consult at
all for IPCARD symptoms, 11 consulted within four weeks for reasons other than those within the
IPCARD survey (i.e. urine infection, cholesterol check, leg ulcer), 12 consulted somemonths later
for a range of similar reasons, and 14 did not consult for at least a further 12 months.
Patient Interviews
Interviews (n = 38) were conducted to explain the help-seeking behaviour of participants and the
issues that had most impact upon help-seeking (see Table 5). There were themes that were com-
mon to all participants, but we also compared the views and experiencesof consulting and non-
consulting participants. Socio-demographiccharacteristics are provided for both groups in Table 6.
Participants generally revealed a ‘wait and see’ attitude towards most symptoms. With age,
some participants appeared to becomemore accepting of illness, and in particular tiredness
and breathlessness. Often symptoms would worsen or persist for months before participants
contacted their GP. Participants indicated they would more likely seek help if they experienced
recurrence of specific, previously experiencedworrisome symptoms; painful symptoms; unfa-
miliar symptoms; and recent changes in symptoms. Specific symptoms that had motivated
greater help seekingwere: severe breathing difficulties; ‘horrible’ chest pains; long-lasting chest
infections; cough; haemoptysis and significant weight loss in the short-term. A degree of sever-
ity was often described as necessary to trigger help seeking.
Even when symptoms were worrisome, however, some participants would hesitate to con-
tact their GP., Female current smokers In particular experienced feelings of guilt for symptoms
perceived as ‘self-inflicted’. Men especially would delay until encouraged by friends/family to
consult GPs. There were fears amongst both men and women of wasting GPs’ time. Issues also
concerned difficulty accessing appointments, especially if in work, and time wasted in waiting
rooms. Even when consulting GPs, participants indicated they did not always report true
smoking habits or symptoms.
Three over-arching themes emerged in which there were differences between the views of
consulters and non-consulters: not wanting to waste time; appraising symptoms; and attitudes
to help-seeking.
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Not wanting to waste time. Amongst those individuals who had not sought help in 12
months, expressed concerns about wasting their GP’s time were shorter and accompanied by
prolonged accounts of the patient not wanting to waste their own time. Talk of patient's wasted
time occurred in 4/7 interviewswith people who had not consulted in the last year and in no
interviewswith regular consulters.
‘[I] hate going to the doctors when you’ve got to sit for an hour or two hours waiting. . ..I’ve
always been a very, very busy person. . . For me I just don’t like the process and I know they
are very, very busy people so I don’t want to waste their time either. . . . [I once got] to the
stage where I thought right OK I’ll go and waste a couple of days going backwards and for-
wards to specialists and doctors and all the rest of it. (05/575)
Table 5. Data relating to symptomatic, non-consulting participants who visited GPs <1 month post survey completion (n = 16).
No. Age Gender Current
smoker
Symptoms reported in
questionnaire
No. of days to
consultation
Reason for
seeking help
Investigations Outcome
1 52 Male Yes Cough >12m, sob> 12m,
fatigue> 12m,
27 Cough Bloods, CXR (lung
changes)
COPD Diagnosed, referred for
SCA
2 61 Male Yes SoB, Fatigue, voice
changes
26 Cough, SoB Bloods,CXR (lung
changes)
Asthma Diagnosed, referred for
SCA
3 58 Female Yes Tiredness 3m 11 Cough Health Check Referred for SCA
4 56 Female Yes Wt loss 17 Wt loss. Bloods–NAD Health check; referred for SCA
5 57 Male Yes Cough 4-12m 19 Cough Bloods–NAD Referred for SCA
6 63 Male Yes C/P >12m 23 Cough - Treated for chest infection Abx &
follow up
7 55 Male No Cough– 3m 21 Cough - Treated for chest infection Abx;
Health Check
8 56 Female Yes Cough >12m 10 Cough - Treated for chest infection
Referred for SCA
9 68 Male No Cough 4-12m, Increasing
ch/infections; voice
changes
5 Cough, Ch/inf CXR (lung
changes)
Emphysema diagnosed
10 54 Male No C/P 4-12m, 24 C/P, breathing
changes
Bloods–NAD Treated for chest infection ABx &
followed up
11 56 Male No C/P>12m, cough >12m,
sweats >12m, Weight loss
27 Slight wheeze Bloods–NAD Watch &Wait (WW); no follow-up
recorded.
12 53 Male Yes Breathing changes>12m 17 Breathing
changes
CXR–NAD Hypertension Diagnosed &
Obesity. Refered for lifestyle
counselling/ SCA
13 83 Female No Tiredness 3m, voice
changes
23 Tiredness Bloods–NAD Depression Diagnosed &
insomnia. Refered for
counselling
14 55 Female Yes Tiredness >12m 14 Fatigue Bloods–NAD Health check; referred for SCA
15 57 Male Yes Weight loss 18 Weight loss CXR–NAD Refered for lifestyle counselling/
SCA
16 65 Female Yes Tiredness >12m 15 Tiredness Health check Refered for SCA
17 67 Female Yes TBA 23 Cough - Treated for chest infection
Referred for SCA
18 74 Male No TBA 16 Cough - Treated for chest infection
Note: Abx: antibiotics; Ch/inf: chest infection; CP: chest pain; COPD: chronic obstructive pulmonary disease; CXR: chest X-ray; NAD: no abnormalities
discovered; SCA: smoking cessation advice; SoB: shortness of breath.
doi:10.1371/journal.pone.0165677.t005
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Fig 1. Post questionnaire help-seeking behaviour of participants with symptoms associated with lung cancer who
had not consulted a GP for 12 months.
doi:10.1371/journal.pone.0165677.g001
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Moreover, non-consulters were the only participants who distanced themselves from con-
sulting behaviours of patients they perceived did waste GP time. Male non-consulters were also
more likely than male consulters to refer to the idea that men are not comfortable seeking help-
ing, and suggested that their family (especially partners) or friends had encouraged them to
consult their GP for a problem.
I try to heal myself as much as I can until the wife gets me and points me in the right direc-
tion and tells me to get down there and I don’t tend to argue with the wife because she’s
always right. . ..I mean I’ve beenmarried about 38 years now, so she knows me quite well
Table 6. Characteristics of interview participants (n = 38).
Characteristic Responders
(n = 38)
Those not
seeing GP in
last 12
months (n-7)
(n =) (%) N (%)
Gender Male 23 61 5 71
Female 15 40 2 29
Age group 50–59 19 50 4 58
60–69 8 21 1 14
70–75 6 16 1 14
75+ 5 13 1 14
Index of multiple deprivation (rank) 1 –Most deprived 7 18 1 14
2 8 21 2 29
3 13 34 1 14
4 7 18 0 0
5 –Least deprived 3 8 3 29
Ethnicity White 37 97 7 100
Black/ Black British 1 3 0 0
Domestic background Married 15 40 4 57
Single 5 13 2 28
Divorced/separated 8 21 0 0
Widowed 5 13 1 14
Living with partner 5 13 0 0
Highest qualification None 9 24 2 28
GCSE/ O-Level 13 34 3 44
A-Level 5 13 0 0
Degree 2 6 0 0
MA, PhD 1 3 0 0
Vocational qualification 7 18 2 28
Missing 1 3 1 14
Employment status F/T employment 11 28 3 44
P/T employment 3 8 1 14
Voluntary work 1 3 0 0
Unemployed 3 8 0 0
Unpaid leave 1 3 0 0
Disabled 2 6 0 0
Retired 17 45 2 44
Smoking status Current smoker 24 63 2 29
Past smoker 14 37 5 71
doi:10.1371/journal.pone.0165677.t006
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and she takes a firm stance at certain stages. And I think she knows some of the symptoms
better than I do and to be honest with you, she tells me that I’m going to the doctors—and I
go. (07/037)
Appraising symptoms. While a degree of severity was often described as necessary to trig-
ger help seeking, non-consulters indicated they had a higher tolerance threshold to symptoms,
giving the least rich accounts of symptoms that triggered them to seek help.
How would I make that judgement call? If I suddenly realised hang on this isn’t getting bet-
ter it needs, I need antibiotics or I need something needs to be done then I will go to the GP
but if it’s just every day stuff I don’t go so it would have to be pretty severe for me to make
an appointment (09/059)
With a combined low threshold for ‘wasting’ their own time at practices, and a high thresh-
old for tolerating worrisome symptoms, there is greater likelihood for these patients to not seek
help.
Attitudes to help-seeking. Both consulters and non-consulters downgraded symptoms
they experienced as minor or not worthy of GP consideration, particularly compared with peo-
ple who are ‘much more ill’ or with greater ‘need’. However, this was more evident amongst
non-consulting participants.
I just feel like I’m wasting their time and there are people that need to be there more than I do.
So I don’t go. (09/059)
Once participants decided their symptoms warranted intervention, non-consulters were
more likely to attempt to self-manage their condition and if that was not successful, to go and
see their GP. Non-consulters were more likely to seek information from the internet and books
and gave the impression they were more empowered to deal with problems themselves, more
self-sufficient.
Discussion
Summary of Findings
This mixedmethods study incorporated a patient symptom assessment survey, clinical notes
review and patient interviews.Triangulation of data from these different sources provides signifi-
cant new insights into how approaches to raising awareness and early detection amongst primary
care populations should be targeted upon those at high-risk of lung cancer. In particular, there is
a clinically relevant group of patients who rarely or never consult their GP, whomay also have
few diagnosed comorbidities, and yet may experienceworrisome symptoms. This group were
predominantly male, younger, smokers and had IMD scores lower than the practice average; the
same group statistically least likely to respond to the questionnaire. As this study has shown,
even if experienced symptoms are not signs of lung cancer, theymay be indicative of other com-
morbidites such as COPD, asthma or emphysema. Targeting these individuals within primary
care with interventions designed to facilitate earlier diagnosismay prove effective and resource-
efficient, and while the focusmay be lung cancer, other comorbiditiesmay also be discovered.
Comparisons with Other Studies and Interpretation of Our Findings
Our survey findings identified a high ‘baseline’ level of reported symptoms associated with
lung cancer within this ‘high-risk’ population sample. While previous evidence found 11% of a
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general population sample experienced a possible cancer symptom within the previous three
months[25], our study found 54% of high-risk individuals reporting at least one symptom in
this period. Even excluding participants experiencing tiredness only, which may be thought
ubiquitous, 40% of all survey respondents experiencedone or more potential lung cancer
symptoms. A study exploring symptoms predictive of lung cancer amongst patients already
referred to secondary care similarly found multiple synchronous symptoms, with symptoms
other than haemoptysis unable to differentiate lung cancer from other diagnoses[26].
Research has shown that individuals with cancer present more frequently in primary care
with non-specific but suggestive symptoms of lung cancer than matched controls[2,27], while
our regression analysis found that no single symptom predicted increasedGP consultations
amongst an at-risk primary care population. The CAPER studies and QCancer algorithums
have provided an evolving set of risk predictionmodels for cancer types, including lung cancer
[27,28], and for the risk of cancer overall[29,30]. Nevertheless, of a sample of patients who sub-
sequently developed lung cancer, between 17%-34% of symptoms presented in the previous 24
months were not caused by the cancer[31]. Our clinical notes review also identified high levels
of comorbidities affecting respiratory function (i.e. COPD), which previous research has found
frequently precedes lung cancer[32]. As Bowen et al. have shown, symptoms associated with
these other diseases are difficult to distinguish from those of lung cancer[33], and both patients
and GPs may attribute new or worsening symptoms to existing comorbidities[16]. Thus, the
high levels of cough, breathlessness and chest infections within our sample confirm previous
evidence that these symptoms alone lack specificity for lung cancer[2,27]. Our study findings
therefore strengthen previous arguments that education about symptoms alone is insufficient
to tackle late diagnosis[13].
Almost half the participants in this study (n = 413/908) indicated they had one or more of
nine potential lung cancer symptoms for which they did not consult their GP. Previous
research found individuals often delay some weeks prior to seeking help as they appraised
symptoms, waiting to see how they developed, and symptoms would often need to significantly
deteriorate to prompt help-seeking[34]. Interview data from our study has found that similar
processes led to extended appraisal intervals even amongst participants who regularly attended
their GP practice, and evidence has previously shown that many patients who die from lung
cancer were already interacting with primary care for other problems prior to diagnosis[35].
Indeed, patients referred to secondary care for suspected lung cancer have been found to have
similar symptom pathways whether or not they were diagnosed as such or were found not to
have cancer[36]. Our study data also indicated participants consulted GPs less frequently for
symptoms they deemedminor (e.g. sweats, voice changes) and for patterns of symptom onset
and progression that were gradual. Indicative of this were the high number of participants who
reported tiredness, unintentional weight loss and ongoing voice changes in the IPCARD ques-
tionnaire, but rarely consulted GPs specifically for these symptoms.
As in previous studies, further reasons given by interviewees in the current study for delay-
ing GP consultation included a fatalistic perception that their condition was ‘self-inflicted’, that
they did not want to ‘burden’ GPs, and may consequently think themselves unworthy of medi-
cal attention[22,37], and that men especially required ‘sanctioning’ or endorsement from
within their social networks to seekmedical help[12,36]. Interviewees in our study also con-
firmed previous evidence that primary care patients experienceddifficultiesbooking conve-
niently timed appointments around work and family commitments, and feared long periods in
waiting rooms[38]. However, our interviewdata also showed participants who had not con-
sulted their GP for at least 12 months were particularly concerned not to waste their own time
in GP practices, had a higher tolerance threshold for symptoms that might trigger others to
consult their GPs, and were more likely to self manage symptoms and seek information from
Promoting Help-Seeking amongst Symptomatic Primary Care Patients at ’High-Risk’ of Lung Cancer
PLOS ONE | DOI:10.1371/journal.pone.0165677 November 4, 2016 15 / 20
sources other than the GP practice. They might therefore be defined as ‘harder to reach’ (HtR)
and of particular concern[39,40]. Of this group, 29% (n = 18) consulted their GP for symptoms
indicative of lung cancer within one month of completing the symptom survey, and of these a
quarter (n = 5) subsequently had comorbidities diagnosed that were previously unknown.
Although for some of these patients no cause was determined for their symptoms, eight were
nevertheless referred for smoking cessation advice (SCA). That these HtR participants were
prepared to seek help for their symptoms after completing the survey indicates it may be a
method for targeting this group; providing the opportunity for health education and interven-
tions encouraging them to more readily consult their GP in the future.
The national ‘Be Clear on Cancer: Three-week cough’ symptom awareness campaign[8],
conducted for three months (April–June) in 2012, increased consulting behaviour and facili-
tated a significant increase in the rate of lung cancer diagnoses in England[41]. However, the
campaign was more effective amongst less deprived patients[42], and the success was accompa-
nied by a large increase in additional workload[43,44], over which GPs had no control[45].
Thus, a more targeted approach of those groups most likely to benefit from an intervention
would promise to be both effective and resource-efficient.Recent studies have also indicated
the potential effectiveness of targeted, local GP-based interventions, which combine symptom
awareness, education, and strategies that reduce complexity in appointment scheduling specifi-
cally for patients at-risk of lung cancer[34,45,46]. A randomised controlled trial of one such
intervention is currently underway in Australia[47].
Our study findings provide further evidence for targeted interventions to facilitate timely
diagnosis of lung cancer, particularly for at-risk patients who rarely consult their GP. The
IPCARD questionnaire used in our study was found to be an effective tool for eliciting symp-
toms experiencedby this patient group, despite their reluctance to consult a GP practice.
Indeed, a significant overall increase in the number of consulations for symptoms identified on
IPCARD by participants occurred in the three months following completion of the question-
naire, compared with the same period prior to receipt of the questionnaire. That questionnaires
were sent to participants from their GP practicemay also have acted to ‘sanction’ their help-
seeking for these specific symptoms, and a practice-based, targeted intervention using IPCARD
would give GPs greater control over additional workloads. An interventionmight include
rapid access routes for this group that reduce structural barriers to consultation, and education
encouraging individuals to more readily report symptoms they experience to GPs in the future.
While the symptomatic, non-consulting group we identified in this study represented a small
proportion (7%) of the overall study sample, extrapolating this proportion across the primary
care population would identify large numbers of patients at risk of lung cancer whomight ben-
efit from a targeted intervention.
Strengths and Limitations
A key strength of the study is that data frommultiple sources have been synthesised to provide
new insights into how awareness and early diagnosis initiatives can be most effectively
designed.Use of the IPCARD questionnaire to elicit symptom prevalence amongst a primary
care population was shown feasible, requiring little work by practices to identify high-risk
patients and mail-out questionnaires. IPCARD response rates were consistent across eight
practices, and although low were comparable with other primary care postal surveys[48].
Despite the increase in participant consultation rates for potential lung cancer symptoms fol-
lowing completion of IPCARD, it is not possible to conclude definitively that any causal rela-
tionship existed. The national ‘Be Clear on Cancer’: ‘three-week cough’ campaign took place in
the three months preceeding the start of this study[8]. However, there was a difference between
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consulting behaviour in the 3 months pre and post questionnaire completion, and for 64.1%
(n = 582/908) participants, the surveywas completed more than 3 months after the end of the
cough campaign.
Conclusion
This is the first study to examine symptoms and consulting behaviour in a primary care popu-
lation at high-risk of lung cancer (50 years old with recent smoking history). Amongst this
population, a small but clinically relevant group of symptomatic non-consulting individuals
were identified, who despite experiencing symptoms potentially indicative of lung cancer, did
not consult their GP for 12 months or more. Community, GP-based interventions targeting
this population group may complement national cancer awareness campaigns to promote
early diagnosis of lung cancer and other comorbidities, without creating large additional work-
loads to already pressurised services.
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